Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoph Schlag

Showing results (51-60 of 68) with videos related to

Pageof 7
Sort By:
British Journal of Cancer|November 7, 2019
Post-neoadjuvant cellular dissociation grading based on tumour budding and cell nest size is associated with therapy response and survival in oesophageal squamous cell carcinomaMoritz Jesinghaus, Melanie Boxberg, Dirk Wilhelm, et al.
United European Gastroenterology Journal|April 12, 2022
Budesonide orodispersible tablets for induction of remission in patients with active eosinophilic oesophagitis: A 6-week open-label trial of the EOS-2 ProgrammeStephan Miehlke, Christoph Schlag, Alfredo J Lucendo, et al.
Endoscopy|April 22, 2022
Motorized spiral enteroscopy: results of an international multicenter prospective observational clinical study in patients with normal and altered gastrointestinal anatomyTorsten Beyna, Tom Moreels, Marianna Arvanitakis, et al.
Endoscopy|June 30, 2025
Quality standards and curriculum for training in cholangiopancreatoscopy: European Society of Gastrointestinal Endoscopy (ESGE) Position StatementGavin Johnson, George Webster, Apostolis Papaefthymiou, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 26, 2022
Monitoring Patients With Eosinophilic Esophagitis in Routine Clinical Practice - International Expert RecommendationsUlrike von Arnim, Luc Biedermann, Seema S Aceves, et al.
Gastroenterology|July 30, 2020
Budesonide Orodispersible Tablets Maintain Remission in a Randomized, Placebo-Controlled Trial of Patients With Eosinophilic EsophagitisAlex Straumann, Alfredo J Lucendo, Stephan Miehlke, et al.
Gastroenterology|March 30, 2019
Efficacy of Budesonide Orodispersible Tablets as Induction Therapy for Eosinophilic Esophagitis in a Randomized Placebo-Controlled TrialAlfredo J Lucendo, Stephan Miehlke, Christoph Schlag, et al.
Gut|March 21, 2015
A randomised, double-blind trial comparing budesonide formulations and dosages for short-term treatment of eosinophilic oesophagitisStephan Miehlke, Petr Hruz, Michael Vieth, et al.
Surgical Endoscopy|May 23, 2025
An optimal curriculum for training in endoscopic ultrasound: a summarized evidence-based literature systematic reviewJulieta Montanelli, Ariosto Honorio Hernandez Lara, Ana Karla Uribe Rivera, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 18, 2024
Efficacy and Safety of Budesonide Orodispersible Tablets for Eosinophilic Esophagitis up to 3 Years: An Open-Label Extension StudyLuc Biedermann, Christoph Schlag, Alex Straumann, et al.
Pageof 7

Showing results (51-60 of 68) with videos related to

Sort By:
Pageof 7
British Journal of Cancer|November 7, 2019
Post-neoadjuvant cellular dissociation grading based on tumour budding and cell nest size is associated with therapy response and survival in oesophageal squamous cell carcinomaMoritz Jesinghaus, Melanie Boxberg, Dirk Wilhelm, et al.
United European Gastroenterology Journal|April 12, 2022
Budesonide orodispersible tablets for induction of remission in patients with active eosinophilic oesophagitis: A 6-week open-label trial of the EOS-2 ProgrammeStephan Miehlke, Christoph Schlag, Alfredo J Lucendo, et al.
Endoscopy|April 22, 2022
Motorized spiral enteroscopy: results of an international multicenter prospective observational clinical study in patients with normal and altered gastrointestinal anatomyTorsten Beyna, Tom Moreels, Marianna Arvanitakis, et al.
Endoscopy|June 30, 2025
Quality standards and curriculum for training in cholangiopancreatoscopy: European Society of Gastrointestinal Endoscopy (ESGE) Position StatementGavin Johnson, George Webster, Apostolis Papaefthymiou, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 26, 2022
Monitoring Patients With Eosinophilic Esophagitis in Routine Clinical Practice - International Expert RecommendationsUlrike von Arnim, Luc Biedermann, Seema S Aceves, et al.
Gastroenterology|July 30, 2020
Budesonide Orodispersible Tablets Maintain Remission in a Randomized, Placebo-Controlled Trial of Patients With Eosinophilic EsophagitisAlex Straumann, Alfredo J Lucendo, Stephan Miehlke, et al.
Gastroenterology|March 30, 2019
Efficacy of Budesonide Orodispersible Tablets as Induction Therapy for Eosinophilic Esophagitis in a Randomized Placebo-Controlled TrialAlfredo J Lucendo, Stephan Miehlke, Christoph Schlag, et al.
Gut|March 21, 2015
A randomised, double-blind trial comparing budesonide formulations and dosages for short-term treatment of eosinophilic oesophagitisStephan Miehlke, Petr Hruz, Michael Vieth, et al.
Surgical Endoscopy|May 23, 2025
An optimal curriculum for training in endoscopic ultrasound: a summarized evidence-based literature systematic reviewJulieta Montanelli, Ariosto Honorio Hernandez Lara, Ana Karla Uribe Rivera, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 18, 2024
Efficacy and Safety of Budesonide Orodispersible Tablets for Eosinophilic Esophagitis up to 3 Years: An Open-Label Extension StudyLuc Biedermann, Christoph Schlag, Alex Straumann, et al.
Pageof 7